Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 천은미 | * |
dc.contributor.author | 박소정 | * |
dc.contributor.author | 신윤영 | * |
dc.contributor.author | 최명근 | * |
dc.date.accessioned | 2024-02-01T16:30:49Z | - |
dc.date.available | 2024-02-01T16:30:49Z | - |
dc.date.issued | 2024 | * |
dc.identifier.issn | 1011-8934 | * |
dc.identifier.issn | 1598-6357 | * |
dc.identifier.other | OAK-34784 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/266929 | - |
dc.description.abstract | Background: Although data on post-coronavirus disease 2019 (COVID-19) conditions are extensive, the prognostic factors affecting symptom duration in non-hospitalized patients with COVID-19 are currently not well known. We aimed to investigate the various prognostic factors affecting symptom duration among outpatients with COVID-19. Methods: Data were analyzed from 257 patients who were diagnosed with mild COVID-19 and visited the 'post-COVID-19 outpatient clinic' between April and December 2022 after a mandatory isolation period. The symptom duration was measured from diagnosis to symptom resolution. Laboratory and pulmonary function test results from their first visit were collected. Results: The mean age of patients was 55.7 years, and the median symptom duration was 57 days. The development of post-COVID-19 conditions (> 12 weeks) were significantly correlated with not using antiviral drugs, leukocytosis (white blood cell > 10,000/mu L), lower 25(OH)D3levels, forced vital capacity (FVC) < 90% predicted, and presence of dyspnea and anxiety/depression. Additionally, in multivariable Cox regression analysis, not using antiviral drugs, lower 25(OH)D3 levels, and having dyspnea were poor prognostic factors for longer symptom duration. Particularly, vitamin D deficiency (< 20 ng/mL) and not using antivirals during the acute phase were independent poor prognostic factors for both post-COVID-19 condition and longer symptom duration. Conclusion: The non-use of antivirals, lower 25(OH)D3 levels, leukocytosis, FVC < 90% predicted, and the presence of dyspnea and anxiety/depression symptoms could be useful prognostic factors for predicting post-COVID-19 condition in outpatients with COVID-19. We suggest that the use of antiviral agents during the acute phase and vitamin D supplements might help reduce COVID-19 symptom duration. | * |
dc.language | English | * |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | * |
dc.subject | COVID-19 | * |
dc.subject | Post-COVID-19 Condition | * |
dc.subject | Prognostic Factors | * |
dc.title | Prognostic Factors for Predicting Post-COVID-19 Condition in Patients With COVID-19 in an Outpatient Setting | * |
dc.type | Article | * |
dc.relation.issue | 2 | * |
dc.relation.volume | 39 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.index | KCI | * |
dc.relation.journaltitle | JOURNAL OF KOREAN MEDICAL SCIENCE | * |
dc.identifier.doi | 10.3346/jkms.2024.39.e23|http://dx.doi.org/10.3346/jkms.2024.39.e23 | * |
dc.identifier.wosid | WOS:001164913200003 | * |
dc.identifier.scopusid | 2-s2.0-85182542619 | * |
dc.author.google | Choi, Myeong Geun | * |
dc.author.google | Joo, Young Woong | * |
dc.author.google | Kim, Min-Ho | * |
dc.author.google | Park, Sojung | * |
dc.author.google | Shin, Yune-Young | * |
dc.author.google | Chun, Eun Mi | * |
dc.contributor.scopusid | 천은미(13410658400) | * |
dc.contributor.scopusid | 박소정(57205588025) | * |
dc.contributor.scopusid | 신윤영(57931193600) | * |
dc.contributor.scopusid | 최명근(57210423283) | * |
dc.date.modifydate | 20240502144901 | * |